Literature DB >> 9773900

Lung function during moderate hypobaric hypoxia in normal subjects and patients with chronic obstructive pulmonary disease.

T A Dillard1, K R Rajagopal, W A Slivka, B W Berg, W J Mehm, N P Lawless.   

Abstract

BACKGROUND: We sought to describe changes in spirometric variables and lung volume subdivisions in healthy subjects and patients with chronic obstructive pulmonary disease (COPD) during moderate acute hypobaric hypoxia as occurs during air travel. We further questioned whether changes in lung function may associate with reduced maximum ventilation or worsened arterial blood gases.
METHODS: Ambulatory patients with COPD and healthy adults comprised the study populations (n = 27). We obtained baseline measurements of spirometry, lung volumes and arterial blood gases from each subject at sea level and repeated measurements during altitude exposure to 8000 ft (2438 m) above sea level in a man-rated hypobaric chamber.
RESULTS: Six COPD patients and three healthy subjects had declines in FVC during altitude exposure greater than the 95% confidence interval (CI) for expected within day variability (p < 0.05). Average forced vital capacity (FVC) declined by 0.123 +/- 0.254 L (mean +/- SD; 95% CI = -0.255, -0.020; p < 0.05) for all subjects combined. The magnitude of decline in FVC did not differ between groups (p > 0.05) and correlated with increasing residual volume (r = -0.455; <0.05). Change in maximum voluntary ventilation (MVV) in the COPD patients equaled -1.244 +/- 4.797 L x min(-1) (95% CI = -3.71, 1.22; p = 0.301). Decline in maximum voluntary ventilation (MVV) in the COPD patients correlated with decreased FVC (r = 0.630) and increased RV (r = -0.546; p < 0.05). Changes in spirometric variables for patients and controls did not explain significant variability in the arterial blood gas variables PaO2, PaCO2 or pH at altitude.
CONCLUSIONS: We observed a decline in forced vital capacity in some COPD patients and normal subjects greater than expected for within day variability. Spirometric changes correlated with changes in reduced maximum voluntary ventilation in the patients but not with changes in resting arterial blood gases.

Entities:  

Mesh:

Year:  1998        PMID: 9773900

Source DB:  PubMed          Journal:  Aviat Space Environ Med        ISSN: 0095-6562


  8 in total

1.  Lung disease at high altitude.

Authors:  Joshua O Stream; Andrew M Luks; Colin K Grissom
Journal:  Expert Rev Respir Med       Date:  2009-12       Impact factor: 3.772

2.  Effect of simulated commercial flight on oxygenation in patients with interstitial lung disease and chronic obstructive pulmonary disease.

Authors:  L M Seccombe; P T Kelly; C K Wong; P G Rogers; S Lim; M J Peters
Journal:  Thorax       Date:  2004-11       Impact factor: 9.139

Review 3.  Underlying lung disease and exposure to terrestrial moderate and high altitude: personalised risk assessment.

Authors:  Kirsten Holthof; Pierre-Olivier Bridevaux; Isabelle Frésard
Journal:  BMC Pulm Med       Date:  2022-05-09       Impact factor: 3.320

Review 4.  Working in permanent hypoxia for fire protection-impact on health.

Authors:  Peter Angerer; Dennis Nowak
Journal:  Int Arch Occup Environ Health       Date:  2003-01-31       Impact factor: 3.015

5.  Respiratory function and blood gas variables in cystic fibrosis patients during reduced environmental pressure.

Authors:  Oliver Thews; Birthe Fleck; Wolfgang E S Kamin; Dirk-Matthias Rose
Journal:  Eur J Appl Physiol       Date:  2004-08       Impact factor: 3.078

6.  The influence of thoracic gas compression and airflow density dependence on the assessment of pulmonary function at high altitude.

Authors:  Troy J Cross; Courtney Wheatley; Glenn M Stewart; Kirsten Coffman; Alex Carlson; Jan Stepanek; Norman R Morris; Bruce D Johnson
Journal:  Physiol Rep       Date:  2018-03

7.  Expiratory Peak Flow and Minute Ventilation Are Significantly Increased at High Altitude versus Simulated Altitude in Normobaria.

Authors:  Nikolaus C Netzer; Linda K Rausch; Matthias Frieß; Kingman P Strohl; Robert Schilz; Michael Decker; Stephan Pramsohler
Journal:  Life (Basel)       Date:  2022-02-17

8.  BTS Clinical Statement on air travel for passengers with respiratory disease.

Authors:  Robina Kate Coker; Alison Armstrong; Alistair Colin Church; Steve Holmes; Jonathan Naylor; Katharine Pike; Peter Saunders; Kristofer John Spurling; Pamela Vaughn
Journal:  Thorax       Date:  2022-02-28       Impact factor: 9.139

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.